Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships ...
H.C. Wainwright downgraded Lava Therapeutics (LVTX) to Neutral from Buy with a price target of $1.50, down from $2. The company announced a ...
H.C. Wainwright lowered the firm’s price target on Harmony Biosciences (HRMY) to $70 from $75 and keeps a Buy rating on the shares following ...
Summit Therapeutics (NASDAQ:SMMT – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC ...
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six research firms that are presently covering the company, MarketBeat.com reports.
16h
Hosted on MSNHC Wainwright & Co. Upgrades Arcus Biosciences (RCUS)Fintel reports that on February 26, 2025, HC Wainwright & Co. upgraded their outlook for Arcus Biosciences (NYSE:RCUS) from ...
19h
Hosted on MSNHC Wainwright & Co. Downgrades Geron (GERN)Fintel reports that on February 26, 2025, HC Wainwright & Co. downgraded their outlook for Geron (NasdaqGS:GERN) from Buy to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results